Clinical Trials Browser

Interventional × Tomography, Optical Coherence × 90 days × Clear all

NCT05859334 2026-03-19

Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment

Phase 2 Recruiting

Glioma

NCT06906562 2026-02-17

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms